Clinical Trial Update: Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating recombinant adenovirus therapy for localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer

Drugs mentioned

• recombinant adenovirus therapy

Snippet

Sponsor: Momotaro-Gene Inc. | Conditions: Localized Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED